Kader, S. et al. 2017. Comparative Study between Oral Hypoglycemic Drugs Repaglinide, Glibenclamide and Rosiglitazone on Some Biochemical Parameters in Type 2 Diabetic Patients. Iraqi Journal of Pharmaceutical Sciences. 18, 2 (Mar. 2017), 32–38. DOI:https://doi.org/10.31351/vol18iss2pp32-38.